These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia. Cacini W; Harden EA; Skau KA Proc Soc Exp Biol Med; 1993 Jul; 203(3):348-53. PubMed ID: 8516346 [TBL] [Abstract][Full Text] [Related]
6. Contribution of acetone and osmotic-diuresis by streptozotocin-induced diabetes in attenuation of cephaloridine nephrotoxicity. Valentovic M; Ball JG; Anestis D Toxicology; 1992; 71(3):245-55. PubMed ID: 1736416 [TBL] [Abstract][Full Text] [Related]
8. Renal accumulation and urinary excretion of cisplatin in diabetic rats. Valentovic MA; Scott LA; Madan E; Yokel RA Toxicology; 1991; 70(2):151-62. PubMed ID: 1763412 [TBL] [Abstract][Full Text] [Related]
9. Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats. Sarangarajan R; Cacini W Pharmacol Toxicol; 1999 Oct; 85(4):169-73. PubMed ID: 10563515 [TBL] [Abstract][Full Text] [Related]
11. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats. Saad SY; Najjar TA Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472 [TBL] [Abstract][Full Text] [Related]
12. Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin. Sarangarajan R; Cacini W Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):66-71. PubMed ID: 15379782 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies of in vitro renal cephaloridine toxicity between normoglycemic and diabetic rats. Valentovic MA; Jeffrey W; Ball JG; Bailly D; Morenas M; Kinder J J Appl Toxicol; 1992 Feb; 12(1):19-24. PubMed ID: 1564248 [TBL] [Abstract][Full Text] [Related]
14. 3,5-Dichloroaniline-induced nephrotoxicity in the Sprague-Dawley rat. Rankin GO; Yang DJ; Teets VJ; Lo HH; Brown PI Toxicol Lett; 1986 Feb; 30(2):173-9. PubMed ID: 3705103 [TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity following acute administration of N-(3,5-dichlorophenyl)succinimide in rats. Rankin GO Toxicology; 1982; 23(1):21-31. PubMed ID: 7089982 [TBL] [Abstract][Full Text] [Related]
16. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats. Ormond PM; Basinger MA; Jones MM; Hande KR J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629 [TBL] [Abstract][Full Text] [Related]
17. Effect of route of administration and dose on diabetes-induced protection against cisplatin nephrotoxicity. Sarangarajan R; Cacini W Proc Soc Exp Biol Med; 1996 Sep; 212(4):362-8. PubMed ID: 8751995 [TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of N-(3-bromophenyl)-2-hydroxysuccinimide: role of halogen groups in the nephrotoxic potential of N-(halophenyl) succinimides. Hong SK; Anestis DK; Hawco NM; Valentovic MA; Brown PI; Rankin GO Toxicology; 1996 Jun; 110(1-3):17-25. PubMed ID: 8658556 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats. Yokozawa T; Yamabe N; Kim HY; Kang KS; Hur JM; Park CH; Tanaka T Biol Pharm Bull; 2008 Jul; 31(7):1422-8. PubMed ID: 18591786 [TBL] [Abstract][Full Text] [Related]
20. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]